Cognitive fatigue

Cognitive fatigue is a reduction in mental capacity felt as effortfulness, slowed processing, and diminished clarity of thought.

As a drug effect it is acute and dose-proportional, fading as the substance wears off — distinct from the chronic fatigue of sleep deprivation or clinical burnout. It ranges from mild sluggishness to a near-total inability to sustain directed thinking.

Cognitive fatigue is frequently reported across a broad range of psychoactive substances. It is most commonly induced at moderate to high doses under stimulants such as amphetamine, MDMA, and cocaine — often peaking after the primary effect subsides — and under deliriants such as diphenhydramine and datura. It also appears under psychedelics such as psilocybin mushrooms and MDA, and under depressants such as alcohol, baclofen, and clonidine.

Cognitive fatigue is felt as a heaviness of mind: thoughts form slowly, concentration slips before it takes hold, and tasks that would ordinarily require little effort feel laborious. Attention drifts without intention. It commonly comes with a sense of physical heaviness and a pull toward stillness or sleep.

Attending to it tends to deepen it — trying to think through the fog surfaces its extent rather than clearing it. At higher doses, particularly under deliriants, the boundary between fatigue and outright confusion becomes difficult to locate.

Cognitive fatigue arises through different pathways depending on the drug class:

• Stimulants — drive sustained release of dopamine and norepinephrine; depletion of these neuromodulators during and after the acute effect reduces the signaling capacity that supports focused attention.
• Deliriants — block muscarinic acetylcholine receptors throughout the brain; acetylcholine is central to sustained attention and working memory, and its broad suppression produces pronounced cognitive slowing.
• Psychedelics — disrupt thalamocortical filtering of information; the processing load of a sustained altered state becomes effortful and fatiguing over the course of a session.
• Depressants — broadly reduce central nervous system activity, slowing neural processing and impairing working memory and executive function.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both likelihood and intensity, and longer sessions under any class compound it. Cognitive fatigue tracks pharmacology more closely than context, though prior sleep debt and existing mental load can amplify it substantially — especially under stimulants and depressants.

Expectation matters too: approaching a session already depleted tends to hasten its onset and deepen its floor. Adequate rest beforehand and prior experience with a substance both reduce its severity.